BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1366@pharmaconomics
DTSTAMP:20260707T020054Z
DTSTART;VALUE=DATE:20250213
DTEND;VALUE=DATE:20250214
SUMMARY:TLX Approval — Illuccix
DESCRIPTION:A final FDA approval decision on Illuccix for prostate cancer imaging is expected Feb 13\, 2025.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/2007191/000200719126000004/chinapr.htm\n\nTrack it: https://pharmaconomics.com/e/1366
URL:https://pharmaconomics.com/e/1366
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TLX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR